Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).


The B apolipoproteins, apo-B48 and apo-B100, are key structural proteins in those classes of lipoproteins considered to be atherogenic [e.g., chylomicron remnants, beta-VLDL, LDL, oxidized LDL, and Lp(a)]. Here we describe the development of transgenic mice expressing high levels of human apo-B48 and apo-B100. A 79.5-kb human genomic DNA fragment containing the entire human apo-B gene was isolated from a P1 bacteriophage library and microinjected into fertilized mouse eggs. 16 transgenic founders expressing human apo-B were generated, and the animals with the highest expression had plasma apo-B100 levels nearly as high as those of normolipidemic humans (approximately 50 mg/dl). The human apo-B100 in transgenic mouse plasma was present largely in lipoproteins of the LDL class as shown by agarose gel electrophoresis, chromatography on a Superose 6 column, and density gradient ultracentrifugation. When the human apo-B transgenic founders were crossed with transgenic mice expressing human apo(a), the offspring that expressed both transgenes had high plasma levels of human Lp(a). Both the human apo-B and Lp(a) transgenic mice will be valuable resources for studying apo-B metabolism and the role of apo-B and Lp(a) in atherosclerosis.

Citations per Year

388 Citations

Semantic Scholar estimates that this publication has 388 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Linton1993TransgenicME, title={Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).}, author={Macrae F Linton and Robert V Farese and Giulia Maria Chiesa and David S. Grass and P Chin and Robert E. Hammer and Helen H. Hobbs and Stephen G. Young}, journal={The Journal of clinical investigation}, year={1993}, volume={92 6}, pages={3029-37} }